Found: 13
Select item for more details and to access through your institution.
Establishment of an artificial urine model in vitro and rat or pig model in vivo to evaluate urinary crystal adherence.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62766-w
- By:
- Publication type:
- Article
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01046-5
- By:
- Publication type:
- Article
Influence of etching mode on bonding performance of self-adhesive flowable resin composites to bovine teeth.
- Published in:
- Dental Materials Journal, 2024, v. 43, n. 3, p. 338, doi. 10.4012/dmj.2023-226
- By:
- Publication type:
- Article
Scanning electron microscopy observation of dentin bond interfaces in different types of resin luting cements.
- Published in:
- Dental Materials Journal, 2024, v. 43, n. 2, p. 179, doi. 10.4012/dmj.2023-219
- By:
- Publication type:
- Article
Treatment of saliva contamination of resin core foundation before adhesive luting.
- Published in:
- Dental Materials Journal, 2024, v. 43, n. 1, p. 36, doi. 10.4012/dmj.2023-073
- By:
- Publication type:
- Article
Influence of surface roughness of universal shade resin composites on color adjustment potential.
- Published in:
- Dental Materials Journal, 2023, v. 42, n. 5, p. 676, doi. 10.4012/dmj.2023-007
- By:
- Publication type:
- Article
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1509, doi. 10.21873/invivo.13599
- By:
- Publication type:
- Article
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1618, doi. 10.1111/1759-7714.14907
- By:
- Publication type:
- Article
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2741
- By:
- Publication type:
- Article
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 18, n. 5, p. N.PAG, doi. 10.3892/mco.2023.2634
- By:
- Publication type:
- Article
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37736-3
- By:
- Publication type:
- Article
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1006, doi. 10.3390/diagnostics10121006
- By:
- Publication type:
- Article